- Home
- ATPC vs NCNA Comparison
ATPC vs NCNA Comparison
Compare ATPC & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATPC
- NCNA
- Stock Information
- Founded
- ATPC 2016
- NCNA 1997
- Country
- ATPC Malaysia
- NCNA United Kingdom
- Employees
- ATPC N/A
- NCNA N/A
- Industry
- ATPC Medical/Nursing Services
- NCNA Biotechnology: Pharmaceutical Preparations
- Sector
- ATPC Health Care
- NCNA Health Care
- Exchange
- ATPC Nasdaq
- NCNA Nasdaq
- Market Cap
- ATPC 4.6M
- NCNA 4.3M
- IPO Year
- ATPC N/A
- NCNA 2017
- Fundamental
- Price
- ATPC $1.33
- NCNA $1.14
- Analyst Decision
- ATPC
- NCNA Buy
- Analyst Count
- ATPC 0
- NCNA 2
- Target Price
- ATPC N/A
- NCNA $25.00
- AVG Volume (30 Days)
- ATPC 4.6M
- NCNA 238.3K
- Earning Date
- ATPC 02-15-2025
- NCNA 11-25-2024
- Dividend Yield
- ATPC N/A
- NCNA N/A
- EPS Growth
- ATPC N/A
- NCNA N/A
- EPS
- ATPC N/A
- NCNA N/A
- Revenue
- ATPC $1,354,042.00
- NCNA N/A
- Revenue This Year
- ATPC N/A
- NCNA N/A
- Revenue Next Year
- ATPC N/A
- NCNA N/A
- P/E Ratio
- ATPC N/A
- NCNA N/A
- Revenue Growth
- ATPC N/A
- NCNA N/A
- 52 Week Low
- ATPC $1.07
- NCNA $0.96
- 52 Week High
- ATPC $19.60
- NCNA $19.40
- Technical
- Relative Strength Index (RSI)
- ATPC 49.56
- NCNA 43.15
- Support Level
- ATPC $1.26
- NCNA $0.96
- Resistance Level
- ATPC $2.93
- NCNA $1.37
- Average True Range (ATR)
- ATPC 0.19
- NCNA 0.15
- MACD
- ATPC 0.02
- NCNA -0.00
- Stochastic Oscillator
- ATPC 14.02
- NCNA 26.09
About ATPC Agape ATP Corporation
Agape ATP Corp through its subsidiaries is engaged in providing health and wellness products and health solution advisory services. The principal activities of the company are to supply high-quality health and wellness products, including a supplement to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system in a body. Its product portfolio includes ATP1s Survivor Select, ATP2 Energized Mineral Concentrate, ATP3 Ionized Cal-Mag, ATP4 Omega Blend, AGN-Vege Fruit Fiber and Others.
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.